All news

Vanguard Health Care Fund is the over-5% client exception in Celldex Therapeutics (CLDX) stake amendment.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Wellington Management Group LLP and its affiliated entities have filed an amended Schedule 13G for Celldex Therapeutics (CLDX), reporting beneficial ownership of 10,951,399 common shares, representing 13.95% of the class. The filing identifies Vanguard Health Care Fund as an exception to the statement that no single client holds more than 5% of the shares.

Read original source

CLDX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.